
|Articles|July 1, 2001
Fluoroquinolone misuse in ER creates concern
Toronto - The first study ever of emergency room use of fluoroquinolones - the newest and most effective of the quinolone antibiotics - paints an "alarming" picture, according to lead researcher, Ebbing Lautenbach, M.D., M.P.H.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
2
Medicus Pharma Completes Phase 2 Enrollment of D-MNA Study to Non-Invasively Treat BCC
3
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
4
Phase 2 Nemolizumab Trial Opens for CPUO
5


















